Blockchain Registration Transaction Record

Quantum BioPharma (QNTM) Settles Disputes with Former CEO, Injects $2.35M Capital

Quantum BioPharma (QNTM) settles disputes with former CEO, Dr. Raza Bokhari, injecting $2.35M into the business. The agreement provides financial stability and focuses on drug development for neurodegenerative disorders like multiple sclerosis.

This news highlights the resolution of a significant legal dispute for Quantum BioPharma, bringing financial stability and closing the chapter on past conflicts. The settlement allows the company to focus on its innovative drug development efforts, particularly in the treatment of neurodegenerative disorders like multiple sclerosis. The injection of non-dilutive capital and the ongoing royalty payments from Celly Nutrition Corp. position Quantum BioPharma for future growth and success.